Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1993 Jan;67(1):112–118. doi: 10.1128/jvi.67.1.112-118.1993

Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas.

S Yanagawa 1, K Kakimi 1, H Tanaka 1, A Murakami 1, Y Nakagawa 1, Y Kubo 1, Y Yamada 1, H Hiai 1, K Kuribayashi 1, T Masuda 1, et al.
PMCID: PMC237343  PMID: 7677952

Abstract

Mouse mammary tumor virus (MMTV) is a slowly transforming retrovirus associated primarily with the induction of mammary tumors. It is widely accepted that T-cell lymphomas of various mouse strains are associated with extra proviruses of MMTV. These extra proviruses showed site-specific rearrangements in the U3 region of long terminal repeats (LTRs), consisting of about 400 nucleotide deletions and occasional substitution resulting in unique tandem repeats. However, the question of whether these mutant MMTVs cause lymphomas has not been experimentally resolved. Here we present distinct evidence that they do. We constructed chimeric MMTVs by replacing the LTR of the recently constructed pathogenic MMTV provirus clone with rearranged LTRs of MMTV proviruses obtained from two DBA/2 mouse lymphoma cell lines, MLA and DL-8, and inoculated them into BALB/c mice. These mice developed lymphomas, but no mammary tumors, 4 to 11 months postinoculation, whereas the original pathogenic MMTV clone alone induced mammary tumors. These results showed that the tissue specificity of MMTV tumorigenesis is determined by the LTR structures.

Full text

PDF
112

Images in this article

114Image
on p.114
115Image
on p.115
115Image
on p.115
116Image
on p.116
117Image
on p.117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Müller V., Vessaz-Shaw A., Fuchs R., Blöchlinger K., Rollini P., Billotte J. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature. 1991 Mar 21;350(6315):207–211. doi: 10.1038/350207a0. [DOI] [PubMed] [Google Scholar]
  2. Ames R. P., Rubin R. C. Morphology of virus-like particles persisting in murine ependymoblastoma in vitro. Cancer Res. 1970 Apr;30(4):1142–1148. [PubMed] [Google Scholar]
  3. BLOOM G. D. Electron microscopy of neoplastic mast cells: a study of the mouse mastocytoma mast cell. Ann N Y Acad Sci. 1963 Feb 26;103:53–86. doi: 10.1111/j.1749-6632.1963.tb53692.x. [DOI] [PubMed] [Google Scholar]
  4. Ball J. K., Arthur L. O., Dekaban G. A. The involvement of a type-B retrovirus in the induction of thymic lymphomas. Virology. 1985 Jan 15;140(1):159–172. doi: 10.1016/0042-6822(85)90455-6. [DOI] [PubMed] [Google Scholar]
  5. Ball J. K., Diggelmann H., Dekaban G. A., Grossi G. F., Semmler R., Waight P. A., Fletcher R. F. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J Virol. 1988 Aug;62(8):2985–2993. doi: 10.1128/jvi.62.8.2985-2993.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ball J. K., McCarter J. A. Repeated demonstration of a mouse leukemia virus after treatment with chemical carcinogens. J Natl Cancer Inst. 1971 Apr;46(4):751–762. [PubMed] [Google Scholar]
  7. Brookes S., Placzek M., Moore R., Dixon M., Dickson C., Peters G. Insertion elements and transitions in cloned mouse mammary tumour virus DNA: further delineation of the poison sequences. Nucleic Acids Res. 1986 Nov 11;14(21):8231–8245. doi: 10.1093/nar/14.21.8231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calafat J., Buijs F., Hageman P. C., Links J., Hilgers J., Hekman A. Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells. J Natl Cancer Inst. 1974 Oct;53(4):977–992. doi: 10.1093/jnci/53.4.977. [DOI] [PubMed] [Google Scholar]
  9. Chino F., Sato F., Sasaki S. Retrovirus particles in spontaneously occurring and radiation-induced tumors in ddY mice. Acta Pathol Jpn. 1981 Mar;31(2):233–247. doi: 10.1111/j.1440-1827.1981.tb01368.x. [DOI] [PubMed] [Google Scholar]
  10. Choi Y., Kappler J. W., Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature. 1991 Mar 21;350(6315):203–207. doi: 10.1038/350203a0. [DOI] [PubMed] [Google Scholar]
  11. Dudley J., Risser R. Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas. J Virol. 1984 Jan;49(1):92–101. doi: 10.1128/jvi.49.1.92-101.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garcia M., Wellinger R., Vessaz A., Diggelmann H. A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas. EMBO J. 1986 Jan;5(1):127–134. doi: 10.1002/j.1460-2075.1986.tb04186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hsu C. L., Fabritius C., Dudley J. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J Virol. 1988 Dec;62(12):4644–4652. doi: 10.1128/jvi.62.12.4644-4652.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Korman A. J., Bourgarel P., Meo T., Rieckhof G. E. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 1992 May;11(5):1901–1905. doi: 10.1002/j.1460-2075.1992.tb05242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kraft R., Ishizaka S. T., Okenquist S. A., Childs G., Lilly F., Lenz J. Absence of mouse mammary tumor virus proviral amplification in chemically induced lymphomas of RF/J mice. J Virol. 1989 Jul;63(7):3200–3204. doi: 10.1128/jvi.63.7.3200-3204.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kwon B. S., Weissman S. M. Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-O-tetradecanoyl phorbol-13-acetate. J Virol. 1984 Dec;52(3):1000–1004. doi: 10.1128/jvi.52.3.1000-1004.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee W. T., Prakash O., Klein D., Sarkar N. H. Structural alterations in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice. Virology. 1987 Jul;159(1):39–48. doi: 10.1016/0042-6822(87)90345-x. [DOI] [PubMed] [Google Scholar]
  18. Lenz J., Celander D., Crowther R. L., Patarca R., Perkins D. W., Haseltine W. A. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. 1984 Mar 29-Apr 4Nature. 308(5958):467–470. doi: 10.1038/308467a0. [DOI] [PubMed] [Google Scholar]
  19. Majors J. E., Varmus H. E. Nucleotide sequences at host-proviral junctions for mouse mammary tumour virus. Nature. 1981 Jan 22;289(5795):253–258. doi: 10.1038/289253a0. [DOI] [PubMed] [Google Scholar]
  20. Matsubayashi Y., Hirama T., Morioka A., Iwashiro M., Masuda T., Uchino H., Takeshita S., Yamagishi H., Udono H., Mieno M. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses. Eur J Immunol. 1990 Sep;20(9):2095–2103. doi: 10.1002/eji.1830200931. [DOI] [PubMed] [Google Scholar]
  21. Michalides R., Wagenaar E., Hilkens J., Hilgers J., Groner B., Hynes N. E. Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice. J Virol. 1982 Sep;43(3):819–829. doi: 10.1128/jvi.43.3.819-829.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Michalides R., Wagenaar E. Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias. Virology. 1986 Oct 15;154(1):76–84. doi: 10.1016/0042-6822(86)90431-9. [DOI] [PubMed] [Google Scholar]
  23. Michalides R., Wagenaar E., Weijers P. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Mol Cell Biol. 1985 Apr;5(4):823–830. doi: 10.1128/mcb.5.4.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Michalides R., van Ooyen A., Nusse R. Mouse mammary tumor virus expression and mammary tumor development. Curr Top Microbiol Immunol. 1983;106:57–78. doi: 10.1007/978-3-642-69357-1_3. [DOI] [PubMed] [Google Scholar]
  25. Moore D. H., Charney J., Lasfargues E. Y., Sarkar N. H., Rubin R. C., Ames R. P. Mammary tumor virus (MTV) virions in a transplantable ependymoblastoam. Proc Soc Exp Biol Med. 1969 Oct;132(1):125–127. doi: 10.3181/00379727-132-34163. [DOI] [PubMed] [Google Scholar]
  26. Nowinski R. C., Sarkar N. H., Old L. J., Moore D. H., Scheer D. I., Hilgers J. Characteristics of the structural components of the mouse mammary tumor virus. II. Viral proteins and antigens. Virology. 1971 Oct;46(1):21–38. doi: 10.1016/0042-6822(71)90003-1. [DOI] [PubMed] [Google Scholar]
  27. Nusse R., van der Ploeg L., van Duijn L., Michalides R., Hilgers J. Impaired maturation of mouse mammary tumor virus precursor polypeptides in lymphoid leukemia cells, producing intracytoplasmic A particles and no extracellular B-type virions. J Virol. 1979 Oct;32(1):251–258. doi: 10.1128/jvi.32.1.251-258.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pourreau-Schneider N., Stephens R. J., Gardner W. U. Viral inclusions and other cytoplasmic components in a Leydig cell murine tumor: an electron microscopic study. Int J Cancer. 1968 Jan 15;3(1):155–162. doi: 10.1002/ijc.2910030119. [DOI] [PubMed] [Google Scholar]
  29. Racevskis J., Beyer H. Amplification of mouse mammary tumor virus genomes in non-mammary tumor cells. J Virol. 1989 Jan;63(1):456–459. doi: 10.1128/jvi.63.1.456-459.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Racevskis J., Sarkar N. H. ML antigen of DBA/2 mouse leukemias: expression of an endogenous murine mammary tumor virus. J Virol. 1982 Jun;42(3):804–813. doi: 10.1128/jvi.42.3.804-813.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ross S. R., Hsu C. L., Choi Y., Mok E., Dudley J. P. Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol Cell Biol. 1990 Nov;10(11):5822–5829. doi: 10.1128/mcb.10.11.5822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. STUECK B., BOYSE E. A., OLD L. J., CARSWELL E. A. ML: A NEW ANTIGEN FOUND IN LEUKAEMIAS AND MAMMARY TUMOURS OF THE MOUSE. Nature. 1964 Sep 5;203:1033–1034. doi: 10.1038/2031033a0. [DOI] [PubMed] [Google Scholar]
  33. Shackleford G. M., Varmus H. E. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9655–9659. doi: 10.1073/pnas.85.24.9655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982;1(4):327–341. [PubMed] [Google Scholar]
  35. Speck N. A., Renjifo B., Golemis E., Fredrickson T. N., Hartley J. W., Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 1990 Feb;4(2):233–242. doi: 10.1101/gad.4.2.233. [DOI] [PubMed] [Google Scholar]
  36. Stephens R. J., Pourreau-Schneider N., Gardner W. U. Cytological morphology of a virus-containing mouse testicular interstitial cell tumor. J Ultrastruct Res. 1968 Mar;22(5):494–507. doi: 10.1016/s0022-5320(68)90037-3. [DOI] [PubMed] [Google Scholar]
  37. Tanaka H., Tamura A., Tsujimura D. Properties of the intracytoplasmic A particles purified from mouse tumors. Virology. 1972 Jul;49(1):61–78. doi: 10.1016/s0042-6822(72)80007-2. [DOI] [PubMed] [Google Scholar]
  38. Theunissen H. J., Paardekooper M., Maduro L. J., Michalides R. J., Nusse R. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats. J Virol. 1989 Aug;63(8):3466–3471. doi: 10.1128/jvi.63.8.3466-3471.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vaidya A. B., Long C. A., Sheffield J. B., Tamura A., Tanaka H. Murine mammary tumor virus deficient in the major glycoprotein: biochemical and biological studies on virions produced by a lymphoma cell line. Virology. 1980 Jul 30;104(2):279–293. doi: 10.1016/0042-6822(80)90333-5. [DOI] [PubMed] [Google Scholar]
  40. Wellinger R. J., Garcia M., Vessaz A., Diggelmann H. Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat. J Virol. 1986 Oct;60(1):1–11. doi: 10.1128/jvi.60.1.1-11.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yanagawa S., Murakami A., Hoshino M., Tanaka H. Structural and functional analysis of long terminal repeats of Suncus murinus mammary tumor virus. J Virol. 1988 Apr;62(4):1235–1242. doi: 10.1128/jvi.62.4.1235-1242.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yanagawa S., Murakami A., Tanaka H. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat. J Virol. 1990 Jun;64(6):2474–2483. doi: 10.1128/jvi.64.6.2474-2483.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES